30th Jun 2021 10:47
Ap24
FORM 38.5(a)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS AND DEALING IN A CLIENT-SERVING CAPACITY
1. KEY INFORMATION
Name of exempt principal trader | J.P. Morgan Securities Plc |
Company dealt in | UDG Healthcare Plc |
Class of relevant security to which the dealings being disclosed relate (Note 1) | €0.05 ordinary shares |
Date of dealing | 29 June 2021 |
2. DEALINGS (Note 2)
(a) Purchases and sales
Total number of relevant securities acquired | Highest price paid (Note 3) | Lowest price paid (Note 3) |
4,685,693 | 10.7200 GBP | 10.6900 GBP |
Total number of securities disposed | Highest price received (Note 3) | Lowest price received (Note 3) |
3,502,697 | 10.7200 GBP | 10.6895 GBP |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 4) | Number of relevant securities (Note 5) | Price per unit (Note 3) |
Equity Swap | Decrease Long
Decrease Short
Increase Long
Increase Short
Opening a Long Position
Opening a Short Position
| 96 5,174 76
4,842 22,737 4,203 303,309 434,139
2,482 10,190 438 30,851 2,445 727
462 156,252 20,000 14,635 150,000 200,000 200,000 150,000
25,790 48,912 27,556 4,042 11,705 6,469 2,920 6 3,367 658
66,451 15,669 107,931 8,565 3,163 26,438 3,208 | 10.7001 GBP 10.7058 GBP 10.7202 GBP
10.6937 GBP 10.7044 GBP 10.7070 GBP 10.7101 GBP 10.7103 GBP
10.6902 GBP 10.6978 GBP 10.6999 GBP 10.7085 GBP 10.7099 GBP 10.7192 GBP
10.6998 GBP 10.7008 GBP 10.7051 GBP 10.7054 GBP 10.7076 GBP 10.7114 GBP 10.7127 GBP 10.7138 GBP
10.6895 GBP 10.6900 GBP 10.6991 GBP 10.7016 GBP 10.7017 GBP 10.7020 GBP 10.7021 GBP 10.7047 GBP 10.7050 GBP 10.7100 GBP
10.6900 GBP 10.7062 GBP 10.7101 GBP 10.7103 GBP 10.7106 GBP 10.7107 GBP 10.7201 GBP |
Ap25
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 5) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 3) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 3) |
|
|
|
3. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and
any other person relating to the voting rights of any relevant securities under any option referred to
on this form or relating to the voting rights or future acquisition or disposal of any relevant securities
to which any derivative referred to on this form is referenced. If none, this should be stated.
Date of disclosure | 30 June 2021 |
Contact name | Alwyn Basch |
Telephone number | 020 7742 7407 |
Name of offeree/offeror with which connected | UDG Healthcare Plc |
Nature of connection (Note 6) | Financial adviser to CD&R Fund XI |
Related Shares:
UDG.L